Anavex Life Sciences is a clinical stage biopharmaceutical company that engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinical clinical trials to treat epilepsy.
Subscribers
34
Comments
9
Submissions
10
New Subscribers
4
New Comments
1
New Total Posts
3
New Upvotes
7
Top Links
Top links shared in AVXL
People Also Like
NSFW
Users who post in this subreddit also engage with these communitiesSort by Engagement
Popular Topics
Top posts shared in AVXL